This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Influenza mRNA Vaccines
April 27, 2023
Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST

Lawrence Thompson
Associate Research Fellow at Pfizer, USA
Speaker

Profile

Lawrence (Larry) C. Thompson, PhD is a Principal Scientist in Analytical Research and Development within BioTherapeutic Pharmaceutical Sciences at Pfizer. He has been with Pfizer for 3.5 years and is currently analytical lead on viral and plasmid based immunotherapeutics. Previously, he spent 3 years in small biotech at two different companies as the analytical lead in the development of serum based cancer diagnostics. He is a graduate of the University of Tennessee (Chattanooga); BS Chemistry in 2001 and Vanderbilt University; PhD Biochemistry 2006. He did his post-doctoral work at the University of Tennessee (Knoxville) from 2006-2010. His education and research path covers a wide breadth including small molecule synthesis; protein cloning, expression and purification; enzyme structure/function determination; protein-protein interaction investigation; serum antigen identification and mAb production/selection; virus/plasmid method development and characterization (to name a few) generating a number of peer reviewed publications and presentations at scientific conferences as well

Agenda Sessions

  • Challenges and Current Approaches Concerning RNA Analytics for the Successful Development of mRNA Vaccines

    12:35pm